71209-012Level 3
Rivastigmine Tartrate (Rivastigmine Tartrate)
**Product type:** Human Prescription Drug
**Active ingredient:** RIVASTIGMINE TARTRATE
**Strength:** 1.5 mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Cadila Pharmaceuticals Limited
**Marketing category:** ANDA (ANDA203844)
**Pharmacologic class:** Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/71209-012Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.